Picture of Neuromeka Co logo

348340 Neuromeka Co Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
IndustrialsHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Neuromeka Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-6,594-8,201-17,654-16,755-21,991
Depreciation
Amortisation
Non-Cash Items4,7501,0305,3787186,836
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital-101-1,729-1,165-8,215966
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-1,056-7,999-12,434-21,930-11,358
Capital Expenditures-293-3,323-30,601-13,787-3,174
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-4,335-15,938-15,79830,355758
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-4,628-19,261-46,40016,568-2,416
Financing Cash Flow Items50
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities13,49726,11357,11315,37111,780
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash7,831-1,149-1,72610,068-2,007